Hydrocephalus: Clinical Trials

7 trials for Hydrocephalus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 withdrawn, 1 not yet recruiting, 1 terminated. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 2, Withdrawn 2, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Hydrocephalus: new trials by email Literature Review of Hydrocephalus trials Research Report on Hydrocephalus

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies
Topical Vancomycin Powder, Standard Perioperative Care - Hydrocephalus, Ventriculoperitoneal Shunt Infection
Phase 4Not yet recruitingAssiut University1642026-05-012026-04-23
Dexmedetomidine and Propofol for Pediatric MRI Sedation
propofol, Dexmedetomidine, Glycopyrrolate - Headache, Tumor
Phase 4CompletedMedical College of Wisconsin402018-03-042020-02-21
ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes Study
ShuntCheck-Micro-Pumper (SCMP), Imaging - Suspected CSF Shunt Obstruction
Phase 4UnknownNeuroDx Development4002013-05-012015-06-23
Effect of Intrathoracic Pressure Regulation on Traumatic Brain Injury
-7 cm H2O ITPR, -12cm H2O ITPR - Head Injury
Phase 4TerminatedAdvanced Circulatory Systems12012-08-012015-02-16
ShuntCheck Versus Radionuclide in Evaluating Shunt Function in Symptomatic NPH Patients
ShuntCheck test - Hydrocephalus
Phase 4CompletedNeuroDx Development202011-06-012015-10-20
Multi-Center Study of ShuntCheck
ShuntCheck test - Blocked Ventricular Shunts
Phase 4WithdrawnNeuroDx Development2009-06-012015-04-14
ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients
Shunt flow detection - Normal Pressure Hydrocephalus
Phase 4WithdrawnNeuroDx Development2008-11-012013-10-29

Narrower conditions

Hydrocephalus, Normal Pressure (2)  ·  Abdominal Neoplasms (1)  ·  Bacterial Infections and Mycoses (1)  ·  Brain Injuries, Traumatic (1)  ·  Craniocerebral Trauma (1)  ·  Epilepsy (1)  ·  Headache (1)  ·  Hepatic Encephalopathy (1)  ·  Intracranial Hemorrhages (1)  ·  Neoplasms (1)  ·  Neurofibromatoses (1)  ·  Postoperative Complications (1)  ·  Prosthesis-Related Infections (1)  ·  Surgical Wound Infection (1)

Broader conditions

Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Nervous System Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Pathologic Processes (2)  ·  Brain Diseases, Metabolic (1)  ·  Brain Injuries (1)  ·  Cardiovascular Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hemorrhage (1)  ·  Hepatic Insufficiency (1)  ·  Heredodegenerative Disorders, Nervous System (1)

Interventions

Dexmedetomidine (1)  ·  Diagnostic Imaging (1)  ·  Glycopyrrolate (1)  ·  Lidocaine (1)  ·  Nitrous Oxide (1)  ·  Propofol (1)  ·  Sevoflurane (1)  ·  Tomography, X-Ray Computed (1)  ·  Vancomycin (1)

Sponsors

NeuroDx Development (4)  ·  Advanced Circulatory Systems (1)  ·  Assiut University (1)  ·  Medical College of Wisconsin (1)

Countries

United States (4)  ·  Egypt (1)

Top investigators

Daniele Rigamonti, MD (1)  ·  David A Frim, MD (1)  ·  David Chesler, MD (1)  ·  David Sandberg, MD (1)  ·  George I Jallo, MD (1)  ·  James Chamberlain, MD (1)  ·  Jeffrey R Leonard, MD (1)  ·  Jonathan E Bennett, MD (1)  ·  Joseph H Piatt, MD (1)  ·  Joseph J Zorc, MD (1)  ·  Joseph R Madsen, MD (1)  ·  Julie C Leonard, MD MPH (1)  ·  Mahmoud H Ragab, MD (1)  ·  Mandeep Tamber, MD (1)

NIH funding

R43NS067770 (1), R44NS067772 (1)